Walgreen Co. v. Collegium Pharmaceutical, Inc.

CourtDistrict Court, N.D. Illinois
DecidedFebruary 18, 2026
Docket1:25-cv-06560
StatusUnknown

This text of Walgreen Co. v. Collegium Pharmaceutical, Inc. (Walgreen Co. v. Collegium Pharmaceutical, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Walgreen Co. v. Collegium Pharmaceutical, Inc., (N.D. Ill. 2026).

Opinion

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

WALGREEN CO.,

Plaintiff, No. 25 CV 6560 v. Judge Manish S. Shah COLLEGIUM PHARMACEUTICAL, INC.,

Defendant.

MEMORANDUM OPINION AND ORDER

Plaintiff Walgreens purchased prescription medications through a wholesale distributor. This distributor contracted with defendant Collegium Pharmaceutical for the purchase of certain pain medications. Pursuant to Collegium’s return policy, Walgreens used a reverse distribution company to return unused medication. Walgreens alleges that Collegium frustrated its returns, thus breaching the return policy, or, alternatively, leading to unjust enrichment in excess of $14 million. Defendant moves to dismiss under Rule 12(b)(2) for lack of personal jurisdiction and Rule 12(b)(6) for failure to state a claim. For the reasons discussed below, defendant’s motion to dismiss is granted. I. Legal Standards Federal Rule of Civil Procedure 12(b)(2) governs dismissals based on lack of personal jurisdiction. When a defendant challenges jurisdiction under Rule 12(b)(2), “the plaintiff bears the burden of demonstrating the existence of jurisdiction.” NBA Props., Inc. v. HANWJH, 46 F.4th 614, 620 (7th Cir. 2022). If the decision is based solely on written materials without an evidentiary hearing, the plaintiff need only make a prima facie showing of personal jurisdiction over the defendant. Matlin v. Spin Master Corp., 921 F.3d 701, 705 (7th Cir. 2019). All well-pleaded facts alleged

in the complaint are taken as true and any factual disputes are resolved in plaintiff’s favor. Id. II. Background Plaintiff Walgreen Co. provides consumer goods as well as pharmacy services through thousands of retail drugstores throughout the United States. [1] ¶ 3.1 Walgreens is an Illinois corporation with its principal place of business in Illinois. [1]

¶ 3. Defendant Collegium Pharmaceutical Inc. develops and commercializes medications. [1] ¶ 4. Collegium is a Virginia corporation with its principal place of business in Massachusetts. [1] ¶ 4.2 Prescription medications are unusable after their expiration date. [1] ¶ 8. Manufacturers typically provide for the return or destruction of medications after or near expiry. [1] ¶ 8. The process of returning and receiving refunds or credits for expired or expiring pharmaceuticals is known as reverse distribution. [1] ¶ 8. Third-

party reverse distribution companies facilitate the return process. [1] ¶ 9.

1 Bracketed numbers refer to entries on the district court docket and page numbers are taken from the CM/ECF header placed at the top of the filing. The facts are taken from the complaint, [1]; the evidence submitted by defendant in opposition to the exercise of jurisdiction, [9-1], [9-2], [9-3], [9-4], [9-5], and [9-6]; and the evidence submitted by plaintiff in response and in support of the exercise of jurisdiction, [16-1], [16-2], [16-3], and [16-4]. 2 The court has subject-matter jurisdiction over this case because the parties are diverse in citizenship and the amount in controversy exceeds $75,000. [1] ¶¶ 3–5; 28 U.S.C. § 1332(a)(1). Walgreens bought many prescription medications through a wholesale distributor. [1] ¶ 13.3 Walgreens’s distributor contracted with Collegium for the purchase of certain medications, which it then resold to Walgreens. [1] ¶ 14.

Walgreens has purchased medications from Collegium through its distributor since 2017. [1] ¶ 17. Collegium published a return policy that allowed the return of medications it manufactured. [1] ¶ 18. This return policy was provided to Walgreens, who bought millions of dollars of medications in reliance on the policy. [1] ¶ 19. Collegium’s return policy allowed pharmacies to return the products that they purchased through a

distributor. [1] ¶ 23; [9-2] at 2. The policy specifically required that returnable products be sent to Collegium’s reverse distribution company in Kentucky. [1] ¶ 25.4 Walgreens used its own reverse distribution company to return unused prescription medications, [1] ¶ 32.5 Employees from Walgreens and Collegium exchanged hundreds of emails and met in Illinois on many occasions to discuss two medications that Walgreens purchased from Collegium. [16-2] ¶ 4. Some of these emails discussed Collegium’s

return policy. See [16-2].

3 Cencora, Inc., Walgreens’s wholesale distributor, is a Pennsylvania corporation with its principal place of business in Pennsylvania. [9-1] ¶ 4; [9-4]. 4 Integrated Commercialization Solutions, LLC, Collegium’s reverse distribution company, is a California company with its principal place of business in Texas. [9-1] ¶ 8; [9-5]. The citizenship of ICS’s members is not mentioned by either party. 5 Inmar RX Solutions, Inc., Walgreens’s reverse distribution company, is a Texas corporation with its principal place of business in North Carolina. [9-6]. Walgreens alleges that Collegium, through its reverse distributor, “began to frustrate and make it impossible” for Walgreens to return medications consistent with the terms of the return policy. [1] ¶ 37. Plaintiff claims that the return policy is

a valid and enforceable contract and filed the present case alleging that defendant has breached this contract by failing to provide credit for plaintiff’s returns. [1] ¶¶ 52– 60. In the alternative, plaintiff brings a claim for unjust enrichment. [1] ¶¶ 61–64. III. Analysis Defendant moves to dismiss on two separate grounds. First, Collegium argues that the court lacks personal jurisdiction over it. In the alternative, defendant argues

that even if personal jurisdiction were present, dismissal is nonetheless appropriate because plaintiff failed to state a claim under Rule 12(b)(6). “A district court sitting in diversity has personal jurisdiction over a nonresident defendant only if a court of the state in which it sits would have jurisdiction.” Purdue Rsch. Found. v. Sanofi-Synthelabo, S.A., 338 F.3d 773, 779 (7th Cir. 2003). The Illinois long-arm statute confers personal jurisdiction if “permitted by the Illinois Constitution and the Constitution of the United States.” 735 ILCS 5/2-

209(c); see also J.S.T. Corp. v. Foxconn Interconnect Tech. Ltd., 965 F.3d 571, 575 (7th Cir. 2020). Thus, the question is whether exercising personal jurisdiction on Collegium “comports with the limits imposed by federal due process.” Walden v. Fiore, 571 U.S. 277, 283 (2014). Federal due process requires that a defendant have minimum contacts with the forum state “such that the maintenance of the suit does not offend ‘traditional notions of fair play and substantial justice.’” Int’l Shoe Co. v. Washington, 326 U.S. 310, 316 (1945) (citations omitted). For cases alleging a breach of contract, “contracting with an out-of-state party alone cannot establish automatically

sufficient minimum contacts in the other party’s home forum.” Purdue Rsch., 338 F.3d at 781 (citing Burger King Corp. v. Rudzewicz, 471 U.S. 462, 478 (1985)).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
Helicopteros Nacionales De Colombia, S. A. v. Hall
466 U.S. 408 (Supreme Court, 1984)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
uBID, Inc. v. GoDaddy Group, Inc.
623 F.3d 421 (Seventh Circuit, 2010)
Telco Leasing, Inc. v. Marshall County Hospital
586 F.2d 49 (Seventh Circuit, 1978)
Robert Felland v. Patrick Clifton
682 F.3d 665 (Seventh Circuit, 2012)
Kopfman v. Ensign Ribbon Burners, LLC
803 F. Supp. 2d 914 (N.D. Illinois, 2011)
Daimler AG v. Bauman
134 S. Ct. 746 (Supreme Court, 2014)
Walden v. Fiore
134 S. Ct. 1115 (Supreme Court, 2014)
Philos Technologies, Inc. v. Philos & D, Inc.
802 F.3d 905 (Seventh Circuit, 2015)
Tai Matlin v. Spin Master Corp.
921 F.3d 701 (Seventh Circuit, 2019)
Charles Curry v. Revolution Laboratories, LLC
949 F.3d 385 (Seventh Circuit, 2020)
J.S.T. Corporation v. Foxconn Interconnect Technolog
965 F.3d 571 (Seventh Circuit, 2020)
Ford Motor Co. v. Montana Eighth Judicial Dist.
592 U.S. 351 (Supreme Court, 2021)
NBA Properties, Incorporated v. HANWJH
46 F.4th 614 (Seventh Circuit, 2022)
B. D. v. Samsung SDI Co., Ltd.
91 F.4th 856 (Seventh Circuit, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
Walgreen Co. v. Collegium Pharmaceutical, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/walgreen-co-v-collegium-pharmaceutical-inc-ilnd-2026.